Location History:
- Thousand Oaks, CA (US) (1999 - 2000)
- Lansdale, PA (US) (1998 - 2001)
Company Filing History:
Years Active: 1998-2001
Title: Melvin Clarence Rutledge, Jr: Innovator in Chemokine Research
Introduction
Melvin Clarence Rutledge, Jr. is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of chemokine research, particularly through his innovative work on IL-8 receptor antagonists. With a total of 10 patents to his name, Rutledge has established himself as a key figure in the development of novel therapeutic compounds.
Latest Patents
Rutledge's latest patents include groundbreaking inventions related to IL-8 receptor antagonists. One of his notable inventions pertains to novel compounds and their use in treating disease states mediated by the chemokine Interleukin-8 (IL-8). Another significant patent focuses on phenyl urea antagonists of the IL-8 receptor, detailing novel compounds of Formula (I) and their application in treating chemokine-mediated diseases.
Career Highlights
Throughout his career, Rutledge has been associated with Smithkline Beecham Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of chemokine interactions and their implications in disease treatment.
Collaborations
Rutledge has collaborated with esteemed colleagues, including Katherine L Widdowson and Daniel F Veber. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in their field.
Conclusion
Melvin Clarence Rutledge, Jr. is a distinguished inventor whose work in chemokine research has led to important advancements in medical treatments. His contributions continue to impact the scientific community and pave the way for future innovations.